Study shows pharmacists knew more about penicillin allergy than MDs

If you have gone through life avoiding certain antibiotics because you think you're allergic to penicillin, you'd probably want to know if you're not actually allergic. A new study shows many physicians who treat patients with "penicillin allergy" listed in their charts may not fully understand important facts about penicillin allergy. They may not be aware penicillin allergy can resolve over time and they don't fully understand the importance of allergy testing to make sure a penicillin allergy currently exists.

The study in Annals of Allergy, Asthma and Immunology, the scientific publication of the American College of Allergy, Asthma and Immunology (ACAAI) examined 276 surveys completed by non-allergist physicians, physician assistants, nurse practitioners and pharmacists at Rochester Regional Health. They found more than 80 percent of the general practitioners surveyed in their system knew a referral to an allergist for testing is appropriate for someone with a reported penicillin allergy. Despite that, the physicians had either never referred their patients to an allergist, or had only done so with one patient a year. In addition, pharmacists surveyed in their system had a better overall understanding of penicillin allergy.

"We were not surprised pharmacists understood the course of penicillin allergy better than other clinicians, given more extensive pharmacology education," says infectious diseases pharmacist Mary Staicu, PharmD, lead author of the study. "Of those surveyed, 78 percent of pharmacists knew penicillin allergy can resolve over time. Only 55 percent of the remaining respondents (non-allergist physicians, physician assistants and nurse practitioners) did." The survey also showed a limited understanding among internists and general practitioners regarding the large numbers of people who report penicillin allergy but have never been tested." Most of the physicians surveyed had been in practice more than 10 years.

Between 10-20 percent of Americans believe they have a penicillin allergy. But previous research has found only 10 percent of those people are truly penicillin allergic. In other words, 9 out of 10 people who think they have penicillin allergy are avoiding it for no reason. Even in people with documented allergy to penicillin, only about 20 percent are still allergic ten years after their initial allergic reaction.

"Our research found a poor understanding of penicillin allergy among non-allergists," says allergist Allison Ramsey, MD, study co-author and ACAAI member. "This was not a surprising finding given the clinical experience of most allergists, but it does provide an excellent opportunity for education on the topic - not just for patients, but for all health care professionals."

People who are labeled penicillin allergic are often prescribed second-line antibiotics, which may have a higher risk of side effects and increased cost. "More than 90 percent of people labeled with a penicillin allergy can tolerate penicillin-based antibiotics," says Dr. Ramsey. "Our survey showed only 30 percent of physician survey respondents knew that. It's important that doctors understand the importance of confirming penicillin allergy. But it's even more important that those who carry the label be educated and tested."

An allergist can work with you to find out if you have a true drug allergy and determine what antibiotics are available for safe and effective treatment. If you're not allergic, you'll be able to safely use antibiotics that are often more effective, and less expensive.

Staicu ML, Soni D, Conn KM, Ramsey A.
A survey of inpatient practitioner knowledge of penicillin allergy at 2 community teaching hospitals.
Ann Allergy Asthma Immunol. 2017 May 20. pii: S1081-1206(17)30339-3. doi: 10.1016/j.anai.2017.04.023.

Most Popular Now

Pfizer begins a Phase 1/2 study to evaluate respir…

Pfizer Inc. (NYSE:PFE) today announced that it has started a Phase 1/2 trial of its respiratory syncytial virus (RSV) vaccine candidate in healthy adult volunteers. RSV i...

Eczema drug effective against severe asthma

Two new studies of patients with difficult-to-control asthma show that the eczema drug dupilumab alleviates asthma symptoms and improves patients' ability to breathe bett...

Most popular vitamin and mineral supplements provi…

The most commonly consumed vitamin and mineral supplements provide no consistent health benefit or harm, suggests a new study led by researchers at St. Michael's Hospital...

AstraZeneca heads to 2018 ASCO Annual Meeting with…

AstraZeneca and MedImmune, its global biologics research and development arm, head to the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, US...

Tiny particles could help fight brain cancer

Glioblastoma multiforme, a type of brain tumor, is one of the most difficult-to-treat cancers. Only a handful of drugs are approved to treat glioblastoma, and the median ...

Novartis data at ASCO and EHA reinforce company's …

Novartis will present data from across its oncology portfolio at the upcoming 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) to be held June 1-5 ...

Spiolto® Respimat® enables greater physical activi…

Boehringer Ingelheim announced data which add to the growing body of evidence that show Spiolto® (tiotropium/olodaterol) Respimat® enables greater physical activity in pa...

New approach to immunotherapy leads to complete re…

A novel approach to immunotherapy developed by researchers at the National Cancer Institute (NCI) has led to the complete regression of breast cancer in a patient who was...

Amgen Foundation and Harvard team up to offer free…

The Amgen Foundation and Harvard University today announced plans to launch a free online science education platform uniquely designed to level the playing field for aspi...

Study demonstrates new treatment for severe asthma

Researchers from McMaster University and the Firestone Institute for Respiratory Health at St. Joseph's Healthcare Hamilton, together with colleagues at other partnering ...

The Pfizer Foundation announces $5 million in gran…

The Pfizer Foundation announced a new $5 million grant commitment to initiatives in low- and middle-income countries that provide family planning access and education for...

Study finds antioxidant-enriched vitamin reduces r…

Researchers at Children's Hospital Colorado (Children's Colorado) and the University of Colorado School of Medicine have found that taking a specially formulated antioxid...